Aurobindo Pharma (AUROPHARMA) — Announcement

Aurobindo Pharma announced that its US FDA-inspected subsidiary Auroactive Pharma completed an inspection ending June 26, 2026 with two observations, which will be addressed within the required timeframe. The company emphasized its commitment to quality standards and confirmed no financial impact on operations, while reaffirming its dedication to maintaining manufacturing excellence.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Limited (AUROPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹87,805.59 Cr P/E: 25.3

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"How does this announcement affect Aurobindo Pharma Limited's outlook?" "What did Aurobindo Pharma Limited announce on 27 June 2026?" "Is this positive or negative for AUROPHARMA?"

Ask AI Free →

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

🔥 Also filed on 27 June 2026

ROSSARI Rossari Biotech Limited Annual Report ROSSARI Rossari Biotech Limited Annual Report PRICOLLTD Pricol Limited Corporate Action RITES RITES Limited Announcement RANASUG Rana Sugars Limited Financial Results RSYSTEMS R Systems International Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.